Family Medicine · Staten Island, NY
NPI
1255358164
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
34 Dumont Ave
Staten Island, NY, 10305
Phone (718) 980-3232
Groups this clinician bills Medicare through
Medicare paid, 2024
$353K
6,383 services
Medicare patients, 2024
465
Average age 74
Drug cost, 2024
$8.1M
33,997 prescriptions
Company payments, 2025
$2,743
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rena Khanukayeva was code 99213 (office e&m - established), 3,791 times for 451 patients. In total Rena Khanukayeva billed 6,383 services in 52 codes, and Medicare paid $353K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 3,791 | 451 | $74.27 | $282K |
| 36415 Venipuncture Blood Collection | Office | 621 | 333 | $8.65 | $5,372 |
| 96372 Injection Administration | Office | 271 | 85 | $11.98 | $3,246 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 221 | 60 | $0.99 | $220 |
| 93000 Electrocardiogram | Office | 169 | 143 | $11.42 | $1,929 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 127 | 21 | $0.78 | $98.58 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 99 | 96 | $98.63 | $9,765 |
| 81002 Clinical Chemistry | Office | 95 | 75 | $3.41 | $324 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 91 | 23 | $0.51 | $46.69 |
| 96365 Intravenous Infusion, Hydration | Office | 90 | 24 | $55.23 | $4,971 |
| 76536 Ultrasound - Nonspecific | Office | 78 | 72 | $93.09 | $7,261 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 77 | 75 | $51.37 | $3,955 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 69 | 52 | $33.38 | $2,303 |
| G0008 Administration of influenza virus vaccine | Office | 53 | 52 | $37.09 | $1,966 |
| 99212 Office E&M - Established | Office | 52 | 47 | $47.47 | $2,469 |
By year: 2022 $412K for 7,044 services; 2023 $390K for 7,032 services; 2024 $353K for 6,383 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 621 | 333 | $8.65 | $5,372 |
| 81002 Clinical Chemistry | 95 | 75 | $3.41 | $324 |
| 87880 Immunoassay | 27 | 27 | $16.20 | $437 |
Medicare prescription drug claims, 2024
In 2024, the drug Rena Khanukayeva prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,118 prescriptions and refills. In total Rena Khanukayeva wrote 33,997 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,118 | 1,459 | 182 | $6,785 |
| Vascepa Icosapent Ethyl | 1,080 | 1,188 | 164 | $378K |
| Atorvastatin Calcium Generic | 924 | 1,256 | 173 | $3,596 |
| Amlodipine Besylate Generic | 855 | 1,057 | 143 | $2,261 |
| Linzess Linaclotide | 852 | 871 | 119 | $443K |
| Metoprolol Succinate Generic | 849 | 1,099 | 127 | $6,258 |
| Diclofenac Sodium Generic | 782 | 797 | 132 | $454K |
| Metformin Hcl Generic | 761 | 945 | 126 | $71K |
| Losartan Potassium Generic | 613 | 815 | 107 | $2,072 |
| Zenpep Lipase/Protease/Amylase | 604 | 662 | 82 | $1.4M |
| Clonidine Hcl Generic | 575 | 602 | 103 | $827 |
| Gabapentin Generic | 518 | 558 | 109 | $1,641 |
| Omeprazole Generic | 484 | 580 | 87 | $1,957 |
| Myrbetriq Mirabegron | 481 | 495 | 62 | $213K |
| Levothyroxine Sodium Generic | 422 | 585 | 59 | $1,773 |
Brand drugs: 10,210 claims; generic drugs: 23,252 claims; opioid claims: 220.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rena Khanukayeva $2,743 ($2,743 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $473.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 21 | $473 |
| Abbvie Inc. ABBV | 33 | $452 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 26 | $351 |
| Scilex Pharmaceuticals Inc. | 10 | $201 |
| Aimmune Therapeutics, Inc. | 6 | $165 |
| Kowa Pharmaceuticals America, Inc. | 11 | $136 |
| Axsome Therapeutics, Inc. AXSM | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $122 |
| Amgen Inc. AMGN | 5 | $118 |
| Pfizer Inc. PFE | 5 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.